Feburic generics acquired additional sales approvals
Generic development of Feburic Tab(febuxostat), a gout treatment, has been fueled.
The Ministry of Food and Drug Safety(MFDS) decided prohibition of its generic sales by the request of the patentee(the original company), but domestic pharmaceutical companies are planning to launch them through p...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
